Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Promising results reported for Senetek's INVICORP for male erectile dysfunction

June 19, 1997

Novartis and Osiris Therapeutics to codevelop bone and cartilage disease therapies

June 18, 1997

First clinical trials results reported for leptin

June 18, 1997

Zonagen reports results of second phase III trial of Vasomax

June 17, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Vitamin E for maternal diabetes-associated malformations in offspring

June 16, 1997

Neurogen reports promising phase I results with antiobesity drug

June 13, 1997

Osiris and Activated Cell Therapy initiate MSC collaboration

June 13, 1997

Testosterone transdermal patch now available in the U.S. in a once-daily formulation

June 13, 1997

Combination insulin sensitizer + alpha-glucosidase inhibitor for diabetes

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...